Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0001209191-21-050759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-11 | 2021-08-09 | GYRE | USMAN NASSIM | Pres, CEO, Dir | P - Purchase | $3.62 | +867 | 18.0K | +5% | +$3,139 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | P | A | 867 | $3.62 | 18,041 | D | — | — | (F1) Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2021. |